13F-HR filed by Consonance Capital Management LP
Consonance Capital Management LP filed this 13F-HR for the quarter ended 2015-03-31, filed 2015-05-14, with 27 holding rows worth $1,098,193,000.
- Accession
- 0001085146-15-001217
- Filer
- CIK 1544773
- Filed
- 2015-05-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2015
A holdings report, 27 entries on the cover page, a total value of $1,098,193,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,098,193,000 with VALUE read as thousands by filing date, 13F file number 028-14924. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 712,186 | $122,806,000 | thousands by filing date | |
| AKORN INC | 009728106 | COM | 1,938,485 | $92,097,000 | thousands by filing date | |
| HYPERION THERAPEUTICS INC | 44915N101 | COM | 1,901,930 | $87,299,000 | thousands by filing date | |
| CARDIOVASCULAR SYSTEMS INC | 141619106 | COMMON STOCK | 2,192,500 | $85,595,000 | thousands by filing date | |
| INSYS THERAPEUTICS INC | 45824V209 | COMMON STOCK | 1,359,247 | $79,013,000 | thousands by filing date | |
| RETROPHIN INC | 761299106 | COM | 3,107,710 | $74,461,000 | thousands by filing date | |
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 1,124,667 | $70,348,000 | thousands by filing date | |
| AbbVie,Inc. | 00287Y109 | COM | 1,177,900 | $68,954,000 | thousands by filing date | |
| ORTHOFIX INTL N V | N6748L102 | COM | 1,580,218 | $56,714,000 | thousands by filing date | |
| ANACOR PHARMACEUTICALS INC | 032420101 | COM | 830,151 | $48,024,000 | thousands by filing date | |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 1,552,962 | $47,552,000 | thousands by filing date | |
| SUPERNUS PHARMACEUTICALS | 868459108 | COM | 3,566,923 | $43,124,000 | thousands by filing date | |
| PERNIX THERAPEUTICS HOLDINGS | 71426V108 | COM | 3,261,484 | $34,865,000 | thousands by filing date | |
| HEALTHWAYS INC | 422245100 | COM | 1,716,307 | $33,811,000 | thousands by filing date | |
| EAGLE PHARMACEUTICALS INC | 269796108 | COM | 735,922 | $30,828,000 | thousands by filing date | |
| OSIRIS THERAPEUTICS INC NEW | 68827R108 | COM | 1,198,336 | $21,067,000 | thousands by filing date | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 4,849,870 | $21,000,000 | thousands by filing date | |
| DERMA SCIENCES INC | 249827502 | COM PAR $.01 | 1,632,627 | $13,828,000 | thousands by filing date | |
| EPIRUS Biopharmaceuticals Inc | 29428P107 | Common Stock | 1,523,773 | $13,638,000 | thousands by filing date | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 2,002,971 | $11,697,000 | thousands by filing date | |
| PROTALIX BIOTHERAPEUTICS INC | 74365A101 | COM | 5,643,750 | $10,046,000 | thousands by filing date | |
| ADMA BIOLOGICS INC | 000899104 | COM | 986,507 | $9,668,000 | thousands by filing date | |
| VERICEL CORP | 92346J108 | COM | 2,352,940 | $8,706,000 | thousands by filing date | |
| Bowater Inc | 09066L105 | COMMON STOCKS | 1,602,550 | $7,965,000 | thousands by filing date | |
| MERUS LABS INTL INC NEW | 59047R101 | COM | 1,368,614 | $2,874,000 | thousands by filing date | |
| VERACYTE INC COM | 92337F107 | Stock | 235,860 | $1,717,000 | thousands by filing date | |
| EHEALTH INC | 28238P109 | COM | 52,900 | $496,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-15-001217 | this filing | 2015-05-14 | acceptance time not in the bulk data set |